Abstract

Objectives: Precise lymph node staging remains a cornerstone in the management of early-stage and locally advanced non-small cell lung cancer (NSCLC), directly influencing surgical planning and multimodal therapy. Despite the widespread use of 2-[18F]FDG PET/CT, occult nodal metastases frequently lead to unexpected upstaging after surgery, potentially affecting prognosis and therapeutic strategies. This study aimed to investigate whether radiomic features derived from preoperative PET/CT scans can predict nodal involvement in patients with early-stage lung cancer. Methods: A retrospective analysis was conducted on 124 patients with cT1N0 NSCLC who underwent 2-[18F]FDG PET/CT scans as part of the preoperative workup, followed by anatomical lung resection and systematic mediastinal lymph node dissection. Radiomic features were extracted from PET predictive of pathological nodal upstaging. Results: During the study period, 67 patients who underwent anatomical lung resection for early-stage lung cancer demonstrated unexpected nodal metastasis; a continuous series of 57 patients with the same clinical TMN was enrolled as a control group. Several radiomic parameters were significantly associated with nodal upstaging. According to variable importance (VIMP) analysis, metabolic tumor volume (MTV), total lesion glycolysis (TLG), run-length non-uniformity (RLNU), and gray-level non-uniformity (GLNU) emerged as the strongest predictors of lymph node involvement. Conclusions: Although the clinical utility of these findings remains to be validated, radiomic analysis of 2-[18F]FDG PET/CT imaging offers non-invasive biomarkers that may enhance the preoperative prediction of nodal involvement in early-stage NSCLC. Integrating radiomics into clinical workflows could improve surgical decision-making, refine patient selection, and reduce the incidence of unforeseen nodal upstaging.

IPC Classification

Keywords